Inovio Pharmaceuticals Inc (NASDAQ: INO) on Friday, plunged -4.80% from the previous trading day, before settling in for the closing price of $2.29. Within the past 52 weeks, INO’s price has moved between $1.74 and $14.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 97.63% over the last five years. The company achieved an average annual earnings per share of 30.90%. With a float of $35.80 million, this company’s outstanding shares have now reached $36.10 million.
The firm has a total of 122 workers. Let’s measure their productivity. In terms of profitability, gross margin is -767.0%, operating margin of -58709.67%, and the pretax margin is -12414736.82%.
Inovio Pharmaceuticals Inc (INO) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Inovio Pharmaceuticals Inc is 0.82%, while institutional ownership is 26.78%.
Inovio Pharmaceuticals Inc (INO) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 30.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.92% during the next five years compared to 13.49% growth over the previous five years of trading.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Trading Performance Indicators
Inovio Pharmaceuticals Inc (INO) is currently performing well based on its current performance indicators. A quick ratio of 3.88 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 393.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.48, a number that is poised to hit -0.84 in the next quarter and is forecasted to reach -2.92 in one year’s time.
Technical Analysis of Inovio Pharmaceuticals Inc (INO)
Analysing the last 5-days average volume posted by the [Inovio Pharmaceuticals Inc, INO], we can find that recorded value of 0.94 million was lower than the volume posted last year of 1.28 million. As of the previous 9 days, the stock’s Stochastic %D was 81.48%. Additionally, its Average True Range was 0.20.
During the past 100 days, Inovio Pharmaceuticals Inc’s (INO) raw stochastic average was set at 7.57%, which indicates a significant decrease from 66.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 101.86% in the past 14 days, which was higher than the 100.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.03, while its 200-day Moving Average is $7.16. Now, the first resistance to watch is $2.30. This is followed by the second major resistance level at $2.42. The third major resistance level sits at $2.52. If the price goes on to break the first support level at $2.08, it is likely to go to the next support level at $1.99. Now, if the price goes above the second support level, the third support stands at $1.87.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Key Stats
Market capitalization of the company is 78.70 million based on 26,100K outstanding shares. Right now, sales total 830 K and income totals -135,120 K. The company made 100 K in profit during its latest quarter, and -32,240 K in sales during its previous quarter.
